Patents by Inventor Andre Laferriere

Andre Laferriere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical salts/co-crystals of pentoxifylline, clonidine and linsidomine with caffeic, protocatechuic or alpha-lipoic acid an use thereof for treatment of pain
    Patent number: 11510926
    Abstract: Disclosed are pharmaceutical salts and co-crystals of pentoxifylline, clonidine and linsidomine with caffeic acid, protocatechuic acid or ?-lipoic acid, and method for preparing thereof. Also disclosed are topical compositions comprising said salts or co-crystals and use thereof for treating pain.
    Type: Grant
    Filed: May 27, 2019
    Date of Patent: November 29, 2022
    Assignee: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
    Inventors: Terence J. Coderre, Oli Abate Fulas, André Laferrière, Ghada Ayoub, Tomislav Fri{hacek over (s)}{hacek over (c)}ić, Dayaker Gandrath, Cristina Mottillo
  • PHARMACEUTICAL SALTS/CO-CRYSTALS OF PENTOXIFYLLINE, CLONIDINE AND LINSIDOMINE WITH CAFFEIC, PROTOCATECHUIC OR alpha-LIPOIC ACID AN USE THEREOF FOR TREATMENT OF PAIN
    Publication number: 20210213025
    Abstract: Disclosed are pharmaceutical salts and co-crystals of pentoxifylline, clonidine and linsidomine with caffeic acid, protocatechuic acid or ?-lipoic acid, and method for preparing thereof. Also disclosed are topical compositions comprising said salts or co-crystals and use thereof for treating pain.
    Type: Application
    Filed: May 27, 2019
    Publication date: July 15, 2021
    Inventors: Terence J. CODERRE, Oli Abate FULAS, André LAFERRIÈRE, Ghada AYOUB, Tomislav FRISCIC, Dayaker GANDRATH, Cristina MOTTILLO
  • TOPICAL TREATMENTS FOR PAIN
    Publication number: 20130029989
    Abstract: The present invention relates to novel compositions and therapeutic methods for the treatment of pain, in particular neuropathic, ischemic, muscle, arthritic or multiple sclerosis pain. The compositions include a combination of an alpha2-adrenergic agonist or a nitric oxide donor combined with a phosphodiesterase (PDE) or a phosphatidic acid (PA) inhibitor, which have been found to act together synergistically to provide effective treatment for pain, especially when administered topically.
    Type: Application
    Filed: April 13, 2011
    Publication date: January 31, 2013
    Applicant: The Royal Institution for the Advancement of Learning/McGill University
    Inventors: Terence Coderre, Andre Laferriere, Vaigunda Ragavendran Jegadeesan